Document Detail


Combination therapy for PD.
MedLine Citation:
PMID:  8255491     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
A Lieberman
Publication Detail:
Type:  Comment; Letter    
Journal Detail:
Title:  Neurology     Volume:  43     ISSN:  0028-3878     ISO Abbreviation:  Neurology     Publication Date:  1993 Dec 
Date Detail:
Created Date:  1994-01-13     Completed Date:  1994-01-13     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  2725-6; author reply 2726-7     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antiparkinson Agents / therapeutic use*
Bromocriptine / therapeutic use
Carbidopa / therapeutic use
Drug Therapy, Combination
Humans
Levodopa / therapeutic use
Parkinson Disease / drug therapy*
Randomized Controlled Trials as Topic
Chemical
Reg. No./Substance:
0/Antiparkinson Agents; 0/Levodopa; 25614-03-3/Bromocriptine; 38821-49-7/Carbidopa
Comments/Corrections
Comment On:
Neurology. 1993 Jan;43(1):21-7   [PMID:  8423888 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Association of the 11778 mitochondrial DNA mutation and demyelinating disease.
Next Document:  The role of the Vabra aspirator in the screening of endometrial carcinoma. Our experience